Syngene International CEO, MD, chairman, board of directors and AGM
NSE: SYNGENEBSE: 539268Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹372.50.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹14,809 Cr359th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 29 Jul 2026
- 67.0
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹90 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 47.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- 4.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹90 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 7.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,44,23153.8% delivered
Syngene International board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonKIRAN MAZUMDAR SHAW
- Managing director and CEOSIDDARTH MITTAL
- Company Secretary and Compliance OfficerChethan Yogesh
11 directors7 independent2 executive2 non-executive
- KIRAN MAZUMDAR SHAW · ChairpersonExecutive · joined Apr 2026 · 4 listed boards · 1 as independent
- SIDDARTH MITTAL · Managing director and CEOExecutive · joined Jul 2026 · 1 listed board
- CATHERINE PATRICIA ROSENBERGNon-executive · joined Aug 2000 · 1 listed board · 1 committee seat
- VINITA BALINon-executive · joined Jul 2025 · 2 listed boards · 1 as independent · 2 committee seats
- SHARMILA ABHAY KARVEIndependent · joined Aug 2019 · reappointed Jul 2022 · 86 months as independent · 5 listed boards · 5 as independent · 7 committee seats, 5 as chair
- NILANJAN ROYIndependent · joined Apr 2024 · reappointed Apr 2024 · 30 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- MANJA BOERMANIndependent · joined Jun 2024 · reappointed Jun 2024 · 27 months as independent · 1 listed board · 1 as independent · 1 committee seat
- SANJAYA SINGHIndependent · joined Jul 2025 · reappointed Jul 2025 · 15 months as independent · 1 listed board · 1 as independent
- SURESH NARAYANANIndependent · joined Aug 2025 · reappointed Aug 2025 · 14 months as independent · 1 listed board · 1 as independent · 2 committee seats
- ARUN CHANDAVARKARIndependent · joined Jul 2026 · reappointed Jul 2026 · 2 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
- VIJAYA CHANDRUIndependent · joined Jul 2026 · reappointed Jul 2026 · 2 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
4 directors who left
- KUSH PARMAR, left 29 Jul 2026: Others
- VIJAY KUCHROO, left 21 Jul 2025: Tenure Completion
- JONATHAN BRITTAN HUNT, left 10 Feb 2025: Others
- SIBAJI BISWAS, left 30 Nov 2024: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 17 Aug 20269 of 11 present6 independent · 18 days in between
- 29 Jul 202610 of 10 present6 independent · 71 days in between
- 18 May 20266 of 10 present3 independent · 18 days in between
- 29 Apr 20269 of 10 present5 independent · 27 days in between
1 earlier meeting
- 1 Apr 202610 of 10 present6 independent
Audit Committee
Chair SHARMILA ABHAY KARVE
SURESH NARAYANAN, NILANJAN ROY, VINITA BALI
- 23 Sep 20264 of 4 present3 independent · 56 days in between
- 28 Jul 20264 of 4 present3 independent · 90 days in between
- 28 Apr 20264 of 4 present3 independent
Nomination and remuneration committee
Chair SURESH NARAYANAN
SHARMILA ABHAY KARVE, CATHERINE PATRICIA ROSENBERG, VINITA BALI, MANJA BOERMAN, SANJAYA SINGH, ARUN CHANDAVARKAR
- 17 Aug 20265 of 7 present4 independent
- 28 Jul 20266 of 6 present4 independent · 70 days in between
- 18 May 20265 of 6 present3 independent
- 28 Apr 20266 of 6 present4 independent
Stakeholders Relationship Committee
Chair NILANJAN ROY
CATHERINE PATRICIA ROSENBERG, MANJA BOERMAN, SURESH NARAYANAN
- 28 Jul 20264 of 4 present3 independent · 91 days in between
- 27 Apr 20264 of 4 present3 independent
Risk Management Committee
Chair NILANJAN ROY
MANJA BOERMAN, VIJAYA CHANDRU
- 27 Jul 20263 of 3 present3 independent · 90 days in between
- 27 Apr 20263 of 3 present3 independent
Corporate Social Responsibility Committee
Chair CATHERINE PATRICIA ROSENBERG
VINITA BALI, SANJAYA SINGH, SHARMILA ABHAY KARVE
- 27 Jul 20264 of 4 present2 independent · 89 days in between
- 28 Apr 20264 of 4 present2 independent
Science and Technology Committee
Chair MANJA BOERMAN
CATHERINE PATRICIA ROSENBERG, SANJAYA SINGH, VIJAYA CHANDRU, ARUN CHANDAVARKAR
- 28 Jul 20264 of 4 present3 independent · 91 days in between
- 27 Apr 20263 of 4 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- BSR & Co. LLPPeer-review certificate valid to Jul 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Syngene International AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Syngene International dividend history
Annual general meeting, 29 Jul 2026
1,46,773 shareholders on the register on 22 Jul 2026; present: 1 promoter and 116 others; votes counted by Pradeep B Kulkarni / V SREEDHARAN & ASSOCIATES.The company's voting result (opens in a new tab)
To consider and adopt the audited financial statements (including the consolidated financial statements) of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors (“the Board”) and auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.13%
Turnout: all 87.31% · promoters 99.48% · institutions 87.85% · other public 3.62%
- To declare a final dividend of Rs. 1.25 per equity share for the Financial Year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- To consider and approve the appointment of Professor Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotation.Ordinary99.67% for0.33% against
Against: promoters 0.00% · institutions 0.82% · other public 0.26%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- Appointment of M/s. S. R. Batliboi & Associates LLP, Chartered Accountants as the statutory auditors of the CompanyOrdinary99.85% for0.15% against
Against: promoters 0.00% · institutions 0.37% · other public 0.25%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- To approve the payment of remuneration to directors in case of absence / inadequate profits in excess of the limits prescribed under the companies act 2013Special89.99% for10.01% against
Against: promoters 0.00% · institutions 25.16% · other public 2.16%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- To approve the appointment of Mr. Siddharth Mittal (DIN: 03230757) as the Managing Director and Chief Executive Officer of the Company and the remuneration payable to himSpecial99.41% for0.59% against
Against: promoters 0.00% · institutions 1.48% · other public 0.61%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- To approve the appointment of Dr. Vijaya Chandru as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.16%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- To approve the appointment of Dr. Arun Chandavarkar as an Independent DirectorSpecial76.25% for23.75% against
Against: promoters 0.00% · institutions 59.72% · other public 1.42%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
- To approve and recommend the appointment of Ms. Vinita Bali (DIN: 00032940) as a Non-Executive DirectorOrdinary98.96% for1.04% against
Against: promoters 0.00% · institutions 2.61% · other public 0.23%
Turnout: all 87.32% · promoters 99.48% · institutions 87.88% · other public 3.62%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 19 Jun 2026, 1 resolution
1,46,402 shareholders on the register on 15 May 2026; votes counted by Pradeep B Kulkarni / V SREEDHARAN & ASSOCIATES.The company's voting result (opens in a new tab)
To approve change in the role of Ms. Kiran Mazumdar-Shaw (DIN: 00347229), from Non-Executive Chairperson to Executive Chairperson (a Key Managerial Personnel) of the Company and payment of Managerial RemunerationMoreLess
SpecialPromoters have an interest in it91.40% for8.60% againstAgainst: promoters 0.00% · institutions 21.57% · other public 7.65%
Turnout: all 87.19% · promoters 99.48% · institutions 86.37% · other public 0.39%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 23 Jul 2025, 6 resolutions
1,45,511 shareholders on the register on 16 Jul 2025; present: 1 promoter and 50 others; votes counted by Pradeep B Kulkarni / V. Sreedharan & Associates.The company's voting result (opens in a new tab)
- To receive, consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2025Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.16%
Turnout: all 90.21% · promoters 99.48% · institutions 92.86% · other public 1.28%
- To declare a final dividend of Rs. 1.25/- per equity share for the financial year ended March 31, 2025Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.31%
Turnout: all 90.21% · promoters 99.48% · institutions 92.86% · other public 1.28%
- To consider and approve the appointment of Professor Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotationOrdinary99.27% for0.73% against
Against: promoters 0.00% · institutions 1.74% · other public 1.61%
Turnout: all 90.21% · promoters 99.48% · institutions 92.86% · other public 1.27%
- To appoint M/s V Sreedharan & Associates, Company Secretaries, as secretarial auditors of the Company and to fix their remunerationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.40%
Turnout: all 90.21% · promoters 99.48% · institutions 92.85% · other public 1.27%
- To approve and recommend the appointment of Ms. Vinita Bali (Din: 00032940), as a Non-Executive DirectorOrdinary99.15% for0.85% against
Against: promoters 0.00% · institutions 2.03% · other public 0.52%
Turnout: all 90.21% · promoters 99.48% · institutions 92.86% · other public 1.27%
- To approve the termination of Syngene Restricted Stock Unit Long Term Incentive Plan FY 2020Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.20%
Turnout: all 90.21% · promoters 99.48% · institutions 92.86% · other public 1.28%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 28 Jun 2025, 5 resolutions
1,44,462 shareholders on the register on 23 May 2025; votes counted by Pradeep B Kulkarni / V SREEDHARAN & ASSOCIATES.The company's voting result (opens in a new tab)
To approve the appointment of Mr. Peter Bains (DIN: 00430937) as Managing Director and Chief Executive Officer of the Company and payment of Managerial Remuneration to an amount not exceeding 7% of the net profits of the Company.MoreLess
Special97.36% for2.64% againstAgainst: promoters 0.00% · institutions 6.31% · other public 2.64%
Turnout: all 90.26% · promoters 99.48% · institutions 93.22% · other public 2.47%
- To approve the appointment of Dr. Sanjaya Singh (DIN: 11122562) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.49%
Turnout: all 90.26% · promoters 99.48% · institutions 93.22% · other public 2.48%
- To approve the appointment of Mr. Suresh Narayanan (DIN: 07246738) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.47%
Turnout: all 90.26% · promoters 99.48% · institutions 93.22% · other public 2.48%
- To approve amendments including increasing the share pool of Performance Share Units under Syngene Long Term Incentive Performance Share Plan 2023.Special80.68% for19.32% against
Against: promoters 0.00% · institutions 46.27% · other public 3.80%
Turnout: all 90.26% · promoters 99.48% · institutions 93.22% · other public 2.48%
- To approve extending the benefits of the ‘Syngene Long Term Incentive Performance Share Plan 2023’, as amended, to the employees of holding company, subsidiary(ies) including future subsidiary(ies).Special80.68% for19.32% against
Against: promoters 0.00% · institutions 46.27% · other public 3.88%
Turnout: all 90.26% · promoters 99.48% · institutions 93.22% · other public 2.47%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 24 Jul 2024, 5 resolutions
Present: 2 promoters and 49 others.The company's voting result (opens in a new tab)
Adoption of Audited Financial Statements: a) To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2024, and the reports of the Board of Directors and Auditors thereon. b) To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, and the report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 87.63% · promoters 99.99% · institutions 92.15% · other public 4.16%
- Declaration of Dividend: To declare a final dividend of Rs. 1.25 per equity share for the financial year ended March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 87.63% · promoters 99.99% · institutions 92.15% · other public 4.16%
- To approve the appointment of Ms. Kiran Mazumdar Shaw (DIN: 00347229) as director liable to retire by rotation.Ordinary98.62% for1.38% against
Against: promoters 0.00% · institutions 3.68% · other public 0.05%
Turnout: all 87.63% · promoters 99.99% · institutions 92.15% · other public 4.16%
- To approve the re-appointment of Dr. Kush Parmar (DIN: 09212020) as an Independent Director of the Company.Special99.84% for0.16% against
Against: promoters 0.00% · institutions 0.44% · other public 0.07%
Turnout: all 87.63% · promoters 99.99% · institutions 92.15% · other public 4.16%
- To approve the appointment of Ms. Manja Boerman (DIN: 10655368) as an Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 87.63% · promoters 99.99% · institutions 92.15% · other public 4.16%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 10 Jun 2024, 3 resolutions
The company's voting result (opens in a new tab)
- To approve the re-appointment of Mr. Jonathan Brittan Hunt (DIN:07774619) as Managing Director and Chief Executive Officer of the CompanyOrdinary96.23% for3.77% against
Against: promoters 0.00% · institutions 10.20% · other public 1.35%
Turnout: all 86.67% · promoters 99.50% · institutions 86.31% · other public 2.00%
- To approve the appointment of Mr. Sibaji Biswas (DIN: 06959449) as Executive Director & Chief Financial Officer of the CompanyOrdinary96.25% for3.75% against
Against: promoters 0.00% · institutions 10.13% · other public 1.31%
Turnout: all 86.67% · promoters 99.50% · institutions 86.31% · other public 2.00%
- To approve the appointment of Mr. Nilanjan Roy (DIN: 02703775) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.64%
Turnout: all 86.67% · promoters 99.50% · institutions 86.31% · other public 2.00%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 26 Jul 2023, 3 resolutions
Present: 2 promoters and 91 others.The company's voting result (opens in a new tab)
Adoption of Audited Financial Statements: a) To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, and the reports of the Board of Directors and Auditors thereon. b) To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, and the report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 84.31% · promoters 99.99% · institutions 86.18% · other public 0.87%
Declaration of Dividend: To declare a final dividend of Rs. 1.25/- per equity share (Re. 0.50 regular dividend and Re. 0.75 as an additional special dividend to mark the 30th anniversary of the founding of the Company in November 1993) for the Financial Year ended March 31, 2023.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.31% · promoters 99.99% · institutions 86.18% · other public 0.87%
- To approve the appointment of Ms. Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotationOrdinaryPromoters have an interest in it99.64% for0.36% against
Against: promoters 0.00% · institutions 1.01% · other public 0.32%
Turnout: all 84.31% · promoters 99.99% · institutions 86.18% · other public 0.86%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 23 Apr 2023, 6 resolutions
The company's voting result (opens in a new tab)
- To approve the Syngene Long Term Incentive Performance Share Plan 2023 and grant of Performance Share Units (PSUs) to eligible employees of the Company.Special94.80% for5.20% against
Against: promoters 0.00% · institutions 15.16% · other public 2.34%
Turnout: all 83.18% · promoters 99.48% · institutions 83.75% · other public 0.65%
- To approve the Syngene Long Term Incentive Outperformance Share Plan 2023 and grant of Performance Share Units (PSUs) to eligible employees of the Company.Special94.80% for5.20% against
Against: promoters 0.00% · institutions 15.16% · other public 2.30%
Turnout: all 83.18% · promoters 99.48% · institutions 83.75% · other public 0.65%
- To approve extending the benefits of the Syngene Long Term Incentive Performance Share Plan 2023 to the employees of Holding Company, subsidiary(ies) including future subsidiary(ies).SpecialPromoters have an interest in it93.13% for6.87% against
Against: promoters 0.00% · institutions 20.03% · other public 4.04%
Turnout: all 83.18% · promoters 99.48% · institutions 83.75% · other public 0.65%
- To approve extending the benefits of the Syngene Long Term Incentive Outperformance Share Plan 2023 to the employees of Holding Company, subsidiary(ies) including future subsidiary(ies).Special93.13% for6.87% against
Against: promoters 0.00% · institutions 20.03% · other public 4.05%
Turnout: all 83.18% · promoters 99.48% · institutions 83.75% · other public 0.65%
To approve the provision of money by the Company for the purchase of its own shares by the Syngene Employees Welfare Trust for the benefit of employees under Syngene Long Term Incentive Performance Share Plan 2023 and Syngene Long Term Incentive Outperformance Share Plan 2023.MoreLess
Special94.80% for5.20% againstAgainst: promoters 0.00% · institutions 15.16% · other public 2.35%
Turnout: all 83.18% · promoters 99.48% · institutions 83.75% · other public 0.65%
- To approve the termination of Syngene Employee Stock Option Plan 2011 (“the ESOP Plan”).Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.53%
Turnout: all 83.35% · promoters 99.48% · institutions 84.25% · other public 0.65%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 29 Jul 2026, 12 fund houses so far (houses' deadline to file 15 Oct 2026)
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To consider and adopt the audited financial statements (including the consolidated financial statements) of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors (“the Board”) and auditors thereonMoreLess
4 for0 against- To declare a final dividend of Rs. 1.25 per equity share for the Financial Year ended March 31, 2026.12 for0 against
- To consider and approve the appointment of Professor Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotation.
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund
- Angel One Mutual FundGovernance Concern: Proposed appointees are Nomination & Remuneration Committee Members and the Board is non-compliant with Section 152 of the Companies Act, 2013. Non-Compliant board composition is failure of Nomination & Remuneration Committee; hence, the members of Nomination & Remuneration Committee should be held accountable.
- Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. No concern identified w.r.t. the merits of appointees. Governance Concern: Proposed appointees are NRC Members and the Board is non-compliant with Section 152 of the Companies Act, 2013. Non-Compliant board composition is failure of NRC; hence, the members of NRC should be held accountable.
9 for3 against - Appointment of M/s. S. R. Batliboi & Associates LLP, Chartered Accountants as the statutory auditors of the Company
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund, Old Bridge Mutual Fund
- Angel One Mutual FundNon-disclosure of Audit fee / remuneration payable to Statutory Auditors in the Notice of the AGM.
- Edelweiss Mutual Fund, Navi Mutual Fund, Old Bridge Mutual FundNo concern on merits of proposed auditors. Non-Compliant with Regulation 36(5) of SEBI LODR: Non-disclosure of Audit fee / remuneration payable to Statutory Auditors in the Notice of the AGM.
8 for4 against - To approve the payment of remuneration to directors in case of absence / inadequate profits in excess of the limits prescribed under the companies act 2013
Against Angel One Mutual Fund, Edelweiss Mutual Fund, HSBC Mutual Fund, Navi Mutual Fund
- Angel One Mutual FundGovernance and Transparency Concern: Inadequate disclosures limit shareholders' ability to make an informed decision. Proposed enabling / blanket approval without adequate disclosures in case of no profits or inadequate profits.
- Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. Governance and Transparency Concern: Inadequate disclosures limit shareholders' ability to make an informed decision. Proposed enabling / blanket approval without adequate disclosures in case of no profits or inadequate profits.
- HSBC Mutual FundA vote AGAINST this resolution is warranted because: • The company has not provided a compelling rationale justifying the need to modify and increase the regulatory limits for the remuneration payable to Directors. • The approval of this request could reduce the accountability of the executives, as they may be paid more than the prescribed remuneration despite the company's poor performance.
8 for4 against - To approve the appointment of Mr. Siddharth Mittal (DIN: 03230757) as the Managing Director and Chief Executive Officer of the Company and the remuneration payable to him
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund, Quantum Mutual Fund
- Angel One Mutual FundGovernance and Transparency Concern: Proposed appointment as non-retiring director will lead to non-compliance with Section 152 of the Companies Act, 2013. The proposed remuneration appears to be excessive and not adequately justified by the Company.
- Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. No concern identified w.r.t. his merits, profile and time commitment. Governance and Transparency Concern: Proposed appointment as non-retiring director will lead to non-compliance with Section 152 of the Companies Act, 2013. The proposed remuneration appears to be excessive and not adequately justified by the Company.
- Quantum Mutual FundWe do not have any concern on the profile and time commitments of Mr. Siddharth Mittal. However, we take note that the proposed remuneration payable to him is Rs. 250 million which is 1.5x the salary paid to the outgoing MD, Peter Bains that stood at Rs. 99.6 million. The proposed remuneration is high when compared with the peers and the size and operations of the company. Further, the company has not provided adequate details of on the performance parameters and granular details for Short Term Incentive and Long-Term Incentive which accounts for 60% of the entire pay. Therefore, we do not favour his appointment as MD & CEO.
8 for4 against - To approve the appointment of Dr. Vijaya Chandru as an Independent Director12 for0 against
- To approve the appointment of Dr. Arun Chandavarkar as an Independent Director
Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, ICICI Prudential Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund, Quantum Mutual Fund, Tata Mutual Fund
- Angel One Mutual FundGovernance Concern: Associated with the Group for more than 10 years; previously held an executive position in the Promoter Entity i.e. Chief Executive Officer & Joint Managing Director of Biocon Limited; and has excessive shareholding in the Promoter Entity.
- DSP Mutual Fund, Jio BlackRock Mutual FundDr. Arun Chandavarkar, 64, is the former CEO and Joint Managing Director of Biocon Ltd., the holding company. He has been associated with Biocon for over three decades before being appointed CEO and Joint Managing Director from 2014 to 2019. He continues to serve as Non-Executive Non-Independent Director at Biocon Biologics Ltd. He was also previously serving as Managing Director of Biocon Biologics Ltd., a group entity and has been serving on their board since 2016. His overall association exceeds ten years; we consider his aggregate tenure with the group. The company must consider appointing him as Non-Executive Non-Independent Director. We do not support the resolution to reappoint Dr. Arun Chandavarkar as Independent Director.
- Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. No concern identified w.r.t. the merit of proposed appointee. Governance Concern: Associated with the Group for more than 10 years; previously held an executive position in the Promoter Entity i.e. CEO & Joint Managing Director of Biocon Limited; and has excessive shareholding in the Promoter Entity.
- ICICI Prudential Mutual FundDr. Arun Chandavarkar, 64, is the former CEO and Joint Managing Director of Biocon Ltd., the holding company. He has been associated with Biocon for over three decades before being appointed the CEO and Joint Managing Director i.e. from 2014 to 2019. He further continues to serve as Non-Executive Non-Independent Director at Biocon Biologics Ltd. and was previously serving as Managing Director of on the board of Biocon Biologics Ltd., a group entity since 2016. The AMC has considered his overall association which exceeds ten years considering the aggregate association with the group and thus voted against the resolution.
- Quantum Mutual FundThe company has sought approval for appointment of Dr. Arun Chandavarkar as independent director. We take a note that he is the former CEO and Joint Managing Director of Biocon Ltd., the holding company from 2014 to 2019. He was also previously serving as Managing Director of Biocon Biologics Ltd, since 2016. He continues to serve as Non-Executive Non-Independent Director at Biocon Biologics Ltd. Given his non-independent association with the company, we do not favour his appointment as independent director.
- Tata Mutual FundNo concern identified w.r.t. the merit of proposed appointee. Governance Concern: Associated with the Group for more than 10 years; previously held an executive position in the Promoter Entity i.e. CEO & Joint Managing Director of Biocon Limited; and has excessive shareholding in the Promoter Entity. he company must consider appointing him as Non-Executive Non-Independent Director. We do not support the resolution to reappoint Dr. Arun Chandavarkar as Independent Director.
4 for8 against - To approve and recommend the appointment of Ms. Vinita Bali (DIN: 00032940) as a Non-Executive Director
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund
- Angel One Mutual FundGovernance Concern: Proposed appointees are Nomination & Remuneration Committee Members and the Board is non-compliant with Section 152 of the Companies Act, 2013. Non-Compliant board composition is failure of Nomination & Remuneration Committee; hence, the members of Nomination & Remuneration Committee should be held accountable.
- Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. No concern identified w.r.t. the merits of appointees. Governance Concern: Proposed appointees are NRC Members and the Board is non-compliant with Section 152 of the Companies Act, 2013. Non-Compliant board composition is failure of NRC; hence, the members of NRC should be held accountable.
9 for3 against
1 proposal not matched to one resolution
To receive, consider and adopt the audited standalone financial statements of the Company including the Balance Sheet as at March 31, 2026, profit and loss account, the cash flow statement for the year ended on that date, report of Board of Directors and auditors thereon and the audited consolidated financial statements of the Company including auditor’s report thereon.MoreLess
8 for0 against
Mutual fund votes, meeting of 19 Jun 2026, 24 fund houses
To approve change in the role of Ms. Kiran Mazumdar-Shaw (DIN: 00347229), from Non-Executive Chairperson to Executive Chairperson (a Key Managerial Personnel) of the Company and payment of Managerial RemunerationMoreLess
Against Franklin Templeton Mutual Fund, HSBC Mutual Fund
- Franklin Templeton Mutual Fund, HSBC Mutual FundA vote AGAINST the proposal is warranted on account of the following concerns: • Kiran Mazumdar-Shaw also serves as the Executive Chairperson of Biocon Limited (Biocon). Executive positions in two companies may make it challenging for a director to devote adequate time to the affairs of each company. • After including the remuneration from Biocon, her remuneration is competitively positioned. • There are no disclosures on the performance parameters, weightage and targets (threshold, target and maximum level) based on which the executive's bonus and variable pay-out would be determined at Biocon. • The board has flexibility to increase remuneration from both the companies. This can potentially increase the aggregate remuneration from both the companies beyond INR 250 million.
22 for2 against
6 earlier meetings
Mutual fund votes, meeting of 23 Jul 2025, 28 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- To receive, consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 202526 for0 against
- To declare a final dividend of Rs. 1.25/- per equity share for the financial year ended March 31, 202528 for0 against
- To consider and approve the appointment of Professor Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotation28 for0 against
- To appoint M/s V Sreedharan & Associates, Company Secretaries, as secretarial auditors of the Company and to fix their remuneration28 for0 against
- To approve and recommend the appointment of Ms. Vinita Bali (Din: 00032940), as a Non-Executive Director
Against Angel One Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund, PPFAS Mutual Fund, Zerodha Mutual Fund
- Angel One Mutual FundGovernance Concern: Existing term ongoing as Independent Director and proposed as Non-Executive-Non-Independent Directorship immediately after completing tenure as Independent Director. Cooling off period of one year not served after completion of term as Independent Director. Appointment as Non-Independent Director raises question over her independence as Independent Director.
- Baroda BNP Paribas Mutual FundAlthough legally compliant, 1 year cooling of period not served.
- Edelweiss Mutual Fund, Groww Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundCompliant with Law. Governance Concern: Existing term ongoing as ID and proposed as NE-NID immediately after completing tenure as ID. Cooling off period of 1-year not served after completion of term as ID. Appointment as Non-Independent Director raises question over her independence as ID.
- PPFAS Mutual FundNo cooling off period served from ID to NED
20 for8 against - To approve the termination of Syngene Restricted Stock Unit Long Term Incentive Plan FY 202028 for0 against
1 proposal not matched to one resolution
- Accept Financial Statements and Statutory Reports2 for0 against
Mutual fund votes, meeting of 28 Jun 2025, 30 fund houses
To approve the appointment of Mr. Peter Bains (DIN: 00430937) as Managing Director and Chief Executive Officer of the Company and payment of Managerial Remuneration to an amount not exceeding 7% of the net profits of the Company.MoreLess
Against Angel One Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PPFAS Mutual Fund, Zerodha Mutual Fund
- Angel One Mutual FundGovernance concern: Cooling off period of one year not being served.
- Baroda BNP Paribas Mutual FundThough legally compliant, cooling off period was not served.
- Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. Governance concern: Cooling off period of 1 year not being served.
- Nippon India Mutual FundGovernance Concern: No cooling off period served by candidate.
- PPFAS Mutual FundCooling off period not being served
21 for9 against- To approve the appointment of Dr. Sanjaya Singh (DIN: 11122562) as an Independent Director of the Company30 for0 against
- To approve the appointment of Mr. Suresh Narayanan (DIN: 07246738) as an Independent Director of the Company30 for0 against
- To approve amendments including increasing the share pool of Performance Share Units under Syngene Long Term Incentive Performance Share Plan 2023.
Against Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Canara Robeco Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Franklin Templeton Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PPFAS Mutual Fund, quant Mutual Fund, Quantum Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund
- Angel One Mutual FundGovernance concern: Potential significant benefit arising to a single employee.
- Axis Mutual FundThe amendments include (i) increase in the pool size by ~4.5 mn options and (ii) increase the maximum options to a single employee in a year to 1% of paid-up share capital. Under the scheme, stock options will be issued at Rs. 10 (face value) and have performance-based vesting linked to individual performance, and other targets approved and communicated by the board. We had supported the original scheme when shareholder approval was sought through a postal ballot in April 2023. However, we have since revised our voting guidelines. We support the grant of deeply discounted options when the vesting is strictly tied to predefined performance criteria, and the targets for such parameters have been clearly disclosed. In the absence of such disclosures, we do not support the resolution.
- Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. Governance concern: Potential significant benefit arising to a single employee.
- Canara Robeco Mutual FundThe amendments include (i) increase in the pool size by ~4.5 mn options and (ii) increase the maximum options to a single employee in a year to 1% of paid-up share capital. Under the scheme, stock options will be issued at Rs. 10 (face value) and have performance-based vesting linked to individual performance, and other targets approved and communicated by the board. Support to the grant of deeply discounted options is contingent upon the vesting being strictly tied to predefined performance criteria and and the targets for such parameters having been clearly disclosed. The company has not disclosed the performance metrics that will determine vesting. In the absence of such disclosures, we do not support the resolution.
- DSP Mutual FundThe amendments include (i) increase in the pool size by ~4.5 mn options and (ii) increase the maximum options to a single employee in a year to 1% of paid-up share capital. Under the scheme, stock options will be issued at Rs. 10 (face value) and have performance-based vesting linked to individual performance, and other targets approved and communicated by the board. We had supported the original scheme when shareholder approval was sought through a postal ballot in April 2023. However, we have since revised our voting guidelines. We support the grant of deeply discounted options when the vesting is strictly tied to predefined performance criteria, and the targets for such parameters have been clearly disclosed. We note that in its response, the company has not disclosed the performance metrics that will determine vesting. In the absence of such disclosures, we do not support the resolution.
- Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • The company has not specified objective performance parameters, performance targets and thresholds for vesting. • The plan provides flexibility for accelerating the vesting period which is generally not considered a good market practice. • The proposal includes grant of PSUs to employees of holding company, without a compelling rationale.
- HDFC Mutual FundPSUs are issued at significant discount to the market price. We do not support the resolution.
- HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The company has not specified objective performance parameters, performance targets and thresholds for vesting. • The plan provides flexibility for accelerating the vesting period which is generally not considered a good market practice. • The proposal includes grant of PSUs to employees of holding company, without a compelling rationale.
- Invesco Mutual FundThe amendments include (i) increase in the pool size by ~4.5 mn options and (ii) increase the maximum options to a single employee in a year to 1% of paid-up share capital. Under the scheme, stock options will be issued at Rs. 10 (face value) and have performance-based vesting linked to individual performance, and other targets approved and communicated by the board. We had supported the original scheme when shareholder approval was sought through a postal ballot in April 2023. However, we have since revised our voting guidelines. We support the grant of deeply discounted options when the vesting is strictly tied to predefined performance criteria, and the targets for such parameters have been clearly disclosed. We note that in its response, the company has not disclosed the performance metrics that will determine vesting. In the absence of such disclosures, we do not support the resolution
- Kotak Mahindra Mutual FundIn the current resolution, the company proposes for few amendments that include (i) increase in the pool size by ~4.5 mn options and (ii) increase the maximum options to a single employee in a year to 1% of paid-up share capital. 1% of issued share capital at present results in total ~ 40,25,370 shares. Technically, the Company can grant ~ 40,25,370 options to an individual employee which represents 60% of the Pool. Considering the current market price of 649.05 (as on 2nd June, 2025) and Exercise Price of 10.00 per share being face value; the maximum economic benefit to an individual employee may lead up to ~257.24 crores, which is quite significant considering the size of the Company. Since the company has not provided adequate reasoning and an absolute cap on the number of options that can be granted per Employee, voting against.
- Mirae Asset Mutual FundStock options at steep discount to CMP does not align with shareholders' interests
- Nippon India Mutual FundPotential excessive benefit to a single employee.
- PPFAS Mutual FundPotential significant benefits arising to a single employee.
- quant Mutual FundRelated to the approval of amendment to the company’s ESOP scheme. Compliant with the law. Governance concern: Potentially significant benefit of up to INR 257cr arising to a single employee.
- Quantum Mutual FundFor the following Governance reason we vote against the resolution. The company has sought approval for amendments to its Syngene Long Term Incentive Performance Share Plan 2023. We take note that the stock units are to be issued at face value, and the company has not provided the performance parameters for vesting of the stock units. Therefore, we do not favour the resolution.
- Tata Mutual FundAs per our understanding ESOPs will be issued at Face Value. We do no support such deep discounted grant of ESOPs.
9 for21 against - To approve extending the benefits of the ‘Syngene Long Term Incentive Performance Share Plan 2023’, as amended, to the employees of holding company, subsidiary(ies) including future subsidiary(ies).
Against Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Canara Robeco Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Franklin Templeton Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PPFAS Mutual Fund, quant Mutual Fund, Quantum Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund
- Angel One Mutual FundGovernance concern: Potential significant benefit arising to a single employee.
- Axis Mutual FundWe do not support the extension scheme to employees of the listed holding company. Further, our view on this resolution is linked to our view on resolution #4. Thus, we do not support the resolution.
- Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. Governance concern: Potential significant benefit arising to a single employee.
- Canara Robeco Mutual FundSupport to the grant of deeply discounted options is contingent upon the vesting being strictly tied to predefined performance criteria and and the targets for such parameters having been clearly disclosed. The company has not disclosed the performance metrics that will determine vesting. In the absence of such disclosures, we do not support the resolution.
- DSP Mutual FundWe generally do not support the extension scheme to employees of the listed holding company. The company has clarified that the resolution pertains to shared resources, i.e., when a group employee is deployed between the holding company and Syngene, with clearly defined responsibilities for each. In such an instance, the respective employee’s compensation is also shared based on the proportion of time devoted to Syngene. Notwithstanding, our view on this resolution is linked to our view on resolution #4. Thus, we do not support the resolution.
- Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • The company has not specified objective performance parameters, performance targets and thresholds for vesting. • The plan provides flexibility for accelerating the vesting period which is generally not considered a good market practice. • The proposal includes grant of PSUs to employees of holding company, without a compelling rationale.
- HDFC Mutual FundPSUs are issued at significant discount to the market price. We do not support the resolution.
- HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The company has not specified objective performance parameters, performance targets and thresholds for vesting. • The plan provides flexibility for accelerating the vesting period which is generally not considered a good market practice. • The proposal includes grant of PSUs to employees of holding company, without a compelling rationale.
- Invesco Mutual FundWe generally do not support the extension scheme to employees of the listed holding company. The company has clarified that the resolution pertains to shared resources, i.e., when a group employee is deployed between the holding company and Syngene, with clearly defined responsibilities for each. In such an instance, the respective employee’s compensation is also shared based on the proportion of time devoted to Syngene. Thus, we do not support the resolution
- Kotak Mahindra Mutual FundWe note that the Company has clarified that only the employees of the Holding Company that have been devoted to the Company will be granted PSUs. However, our view is linked to resolution #4. Hence voting against.
- Mirae Asset Mutual FundStock options at steep discount to CMP does not align with shareholders' interests
- Nippon India Mutual FundPotential excessive benefit to a single employee.
- PPFAS Mutual FundInterlinked with the other Performance Share Units resolution
- quant Mutual FundRelated to the approval of amendment to the company’s ESOP scheme. Compliant with the law. Governance concern: Potentially significant benefit of up to INR 257cr arising to a single employee.
- Quantum Mutual FundFor the following Governance reason we vote against the resolution. The company has sought approval for amendments to its Syngene Long Term Incentive Performance Share Plan 2023. We take note that the stock units are to be issued at face value, and the company has not provided the performance parameters for vesting of the stock units. Therefore, we do not favour the resolution.
- Tata Mutual FundPertaining to Resolution number 4. We do not support the resolution.
9 for21 against
Mutual fund votes, meeting of 24 Jul 2024, 23 fund houses
Adoption of Audited Financial Statements: a) To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2024, and the reports of the Board of Directors and Auditors thereon. b) To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, and the report of the Auditors thereon.MoreLess
23 for0 against- Declaration of Dividend: To declare a final dividend of Rs. 1.25 per equity share for the financial year ended March 31, 2024.23 for0 against
- To approve the appointment of Ms. Kiran Mazumdar Shaw (DIN: 00347229) as director liable to retire by rotation.
Against Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Zerodha Mutual Fund
- Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundRe-appointment compliant with law. Governance Concern: Excessive Time Commitments.
- Zerodha Mutual FundExcessive Time Commitments.
18 for5 against - To approve the re-appointment of Dr. Kush Parmar (DIN: 09212020) as an Independent Director of the Company.23 for0 against
- To approve the appointment of Ms. Manja Boerman (DIN: 10655368) as an Independent Director of the Company.23 for0 against
Mutual fund votes, meeting of 10 Jun 2024, 26 fund houses
- To approve the re-appointment of Mr. Jonathan Brittan Hunt (DIN:07774619) as Managing Director and Chief Executive Officer of the Company
Against Axis Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Invesco Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund
- Axis Mutual Fund, DSP Mutual Fund, Navi Mutual FundJonathan Hunt, 55, was appointed as Managing Director and CEO of the company for five years with effect from 1 April 2020 in the FY20 AGM. While we support Jonathan Hunt’s reappointment as Managing Director and CEO, we do not support the resolution since his estimated proposed remuneration for FY25 remuneration at Rs. 202.7 mn (including estimated fair value of options granted) is high in comparison to peers. Further, the company has not provided any details regarding the number of stock options/RSUs that he may granted during his proposed term, nor has it capped the total proposed remuneration payable during his term. Therefore, we are unable to support the resolution.
- Edelweiss Mutual FundTwo seperate resolutions have been clubbed together which does not denote right governance.
- Groww Mutual FundRe-appointment compliant with law. No concern on the merits of proposed appointee. Transparency Concern: Board attendance not disclosed as per SS-2.
- Invesco Mutual FundJonathan Hunt, 55, was appointed as Managing Director and CEO of the company for five years with effect from 1 April 2020 in the FY20 AGM. While we support Jonathan Hunt’s reappointment as Managing Director and CEO, we do not support the resolution since his estimated proposed remuneration for FY25 remuneration at Rs. 202.7 mn (including estimated fair value of options granted) is high in comparison to peers. Further, the company has not provided any details regarding the number of stock options/RSUs that he may granted during his proposed term, nor has it capped the total proposed remuneration payable during his term. Therefore, we are unable to support the resolution
- Nippon India Mutual FundRemuneration is high
19 for7 against - To approve the appointment of Mr. Sibaji Biswas (DIN: 06959449) as Executive Director & Chief Financial Officer of the Company
Against Axis Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Invesco Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund
- Axis Mutual Fund, DSP Mutual Fund, Navi Mutual FundSibaji Biswas, 54, was appointed as the CFO of Syngene in December 2019 and is a member of the Executive Committee. The company proposes to appoint him as Executive Director and CFO for five years from 1 April 2024. While we support Sibaji Biswas’ appointment as Executive Director and CFO, we do not support the resolution because his estimated proposed remuneration for FY25 remuneration at Rs. 71.5 mn (including estimated fair value of options granted) is high in comparison to peers. Further, the company has not provided any details regarding the number of stock options/RSUs that he may granted during his proposed term, nor has it capped the total proposed remuneration payable during his term. Therefore, we are unable to support the resolution.
- Edelweiss Mutual FundTwo seperate resolutions have been clubbed together which does not denote right governance.
- Invesco Mutual FundSibaji Biswas, 54, was appointed as the CFO of Syngene in December 2019 and is a member of the Executive Committee. The company proposes to appoint him as Executive Director and CFO for five years from 1 April 2024. While we support Sibaji Biswas’ appointment as Executive Director and CFO, we do not support the resolution because his estimated proposed remuneration for FY25 remuneration at Rs. 71.5 mn (including estimated fair value of options granted) is high in comparison to peers. Further, the company has not provided any details regarding the number of stock options/RSUs that he may granted during his proposed term, nor has it capped the total proposed remuneration payable during his term. Therefore, we are unable to support the resolution
- Nippon India Mutual FundRemuneration is high
20 for6 against - To approve the appointment of Mr. Nilanjan Roy (DIN: 02703775) as an Independent Director of the Company26 for0 against
Mutual fund votes, meeting of 26 Jul 2023, 18 fund houses
Adoption of Audited Financial Statements: a) To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, and the reports of the Board of Directors and Auditors thereon. b) To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, and the report of the Auditors thereon.MoreLess
18 for0 againstDeclaration of Dividend: To declare a final dividend of Rs. 1.25/- per equity share (Re. 0.50 regular dividend and Re. 0.75 as an additional special dividend to mark the 30th anniversary of the founding of the Company in November 1993) for the Financial Year ended March 31, 2023.MoreLess
18 for0 against- To approve the appointment of Ms. Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotation18 for0 against
Mutual fund votes, meeting of 23 Apr 2023, 17 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- To approve the Syngene Long Term Incentive Performance Share Plan 2023 and grant of Performance Share Units (PSUs) to eligible employees of the Company.2 for0 against
- To approve the Syngene Long Term Incentive Outperformance Share Plan 2023 and grant of Performance Share Units (PSUs) to eligible employees of the Company.2 for0 against
- To approve extending the benefits of the Syngene Long Term Incentive Performance Share Plan 2023 to the employees of Holding Company, subsidiary(ies) including future subsidiary(ies).
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:- The scheme permits PSUs to be issued with an exercise price at a deep discount to the market price, as on grant date.- The exact performance conditions and targets for vesting have not been disclosed.- The proposal includes grant of stock options to employees of holding companies.
2 for1 against - To approve extending the benefits of the Syngene Long Term Incentive Outperformance Share Plan 2023 to the employees of Holding Company, subsidiary(ies) including future subsidiary(ies).
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:- The scheme permits PSUs to be issued with an exercise price at a deep discount to the market price, as on grant date.- The exact revenue target for vesting has not been disclosed. In the absence of information, it is difficult to ascertain if the revenue targets will be sufficiently stretching.- The proposal includes grant of stock options to employees of holding companies.
2 for1 against To approve the provision of money by the Company for the purchase of its own shares by the Syngene Employees Welfare Trust for the benefit of employees under Syngene Long Term Incentive Performance Share Plan 2023 and Syngene Long Term Incentive Outperformance Share Plan 2023.MoreLess
Against HDFC Mutual Fund, HSBC Mutual Fund
- HDFC Mutual FundESOPs are being granted at a significant discount to market price
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:- The scheme permits PSUs to be issued with an exercise price at a deep discount to the market price, as on grant date.- The exact revenue target for vesting has not been disclosed. In the absence of information, it is difficult to ascertain if the revenue targets will be sufficiently stretching.- The proposal includes grant of stock options to employees of holding companies.
15 for2 against- To approve the termination of Syngene Employee Stock Option Plan 2011 (“the ESOP Plan”).17 for0 against
14 proposals not matched to one resolution
- 1) Approve Syngene Long Term Incentive Performance Share Plan 2023 (Plan 2023).1 for0 against
- 2) Approve Syngene Long Term Incentive Outperformance Share Plan 2023 (Outperformance Plan 2023).1 for0 against
- 3) Approve extension of the Syngene Long Term Incentive Performance Share Plan 2023 (Plan 2023) to the employees of the holding company and subsidiaries of the company (including future subsidiaries).1 for0 against
4) Approve extension of the Syngene Long Term Incentive Outperformance Share Plan 2023 (Outperformance Plan 2023) to the employees of the holding company and subsidiaries of the company (including future subsidiaries).MoreLess
1 for0 againstApprove extension of the Syngene Long Term Incentive Outperformance Share Plan 2023 (Outperformance Plan 2023) to the employees of the holding company and subsidiaries of the company (including future subsidiaries)MoreLess
2 for0 against- Approve extension of the Syngene Long Term Incentive Performance Share Plan 2023 (Plan 2023) to the employees of the holding company and subsidiaries of the company (including future subsidiaries)2 for0 against
- Approve Syngene Long Term Incentive Outperformance Share Plan 2023 and Grant of Performance Share Units to Eligible Employees of the Company
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:- The scheme permits PSUs to be issued with an exercise price at a deep discount to the market price, as on grant date.- The exact revenue target for vesting has not been disclosed. In the absence of information, it is difficult to ascertain if the revenue targets will be sufficiently stretching.- The proposal includes grant of stock options to employees of holding companies.
0 for1 against - Approve Syngene Long Term Incentive Outperformance Share Plan 2023 (Outperformance Plan 2023)2 for0 against
- Approve Syngene Long Term Incentive Performance Share Plan 2023 and Grant of Performance Share Units to Eligible Employees of the Company
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:- The scheme permits PSUs to be issued with an exercise price at a deep discount to the market price, as on grant date.- The exact performance conditions and targets for vesting have not been disclosed.- The proposal includes grant of stock options to employees of holding companies.
0 for1 against - Approve Syngene Long Term Incentive Performance Share Plan 2023 (Plan 2023)2 for0 against
To approve the syngene long term incentive outperformance share plan 2023 and grant of performance share units to eligible employees of the company not exceeding 14,00,000 PSUs being 0.35% (approximate) of the paid-up capital of the Company as on March 15, 2023 (or such other adjusted figure for any bonus, stock splits or consolidations or other reorganization of the capital structure of the Company as may be applicable from time to time), which are exercisable into not more than 14,00,000 equity shares of face value of Rs. 10/- each at any point of time.MoreLess
Against HDFC Mutual Fund
- HDFC Mutual FundESOPs are being granted at a significant discount to market price
10 for1 againstTo approve the syngene long term incentive performance share plan 2023 and grant of performance share units to eligible employees of the company not exceeding 22,00,000 PSUs being 0.55% (approximate) of the paid-up capital of the Company as on March 15, 2023 (or such other adjusted figure for any bonus, stock splits or consolidations or other reorganization of the capital structure of the Company as may be applicable from time to time), which are exercisable into not more than 22,00,000 equity shares of face value of Rs. 10/- each at any point of time.MoreLess
Against HDFC Mutual Fund
- HDFC Mutual FundESOPs are being granted at a significant discount to market price
10 for1 againstTo extend the benefits of the Syngene Long Term Incentive Outperformance Share Plan 2023 (the Plan) including the grant of Performance Share Units (PSUs) to such person(s) who are in employment, whether working in India or outside India and directors whether a whole-time director or not (other than promoters or member of the promoter group of the Company, an employee who is a promoter or a person belonging to the promoter group, Independent Directors and Directors holding directly or indirectly more than 10% of the outstanding Equity Shares of the Company).MoreLess
Against HDFC Mutual Fund
- HDFC Mutual FundESOPs are being granted at a significant discount to market price
10 for1 againstTo extend the benefits of the Syngene Long Term Incentive Performance Share Plan 2023 (the Plan) including the grant of Performance Share Units (PSUs) to such person(s) who are in employment, whether working in India or outside India and directors whether a whole-time director or not (other than promoters or member of the promoter group of the Company, an employee who is a promoter or a person belonging to the promoter group, Independent Directors and Directors holding directly or indirectly more than 10% of the outstanding Equity Shares of the Company) of the holding company or subsidiary company (ies) or employees of any future subsidiary company (ies).MoreLess
Against HDFC Mutual Fund
- HDFC Mutual FundESOPs are being granted at a significant discount to market price
10 for1 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines, tax disputes and stakes in unlisted companies
Reported in the filing for the quarter to Sep 2026.
- Unlisted stake boughtAmpin C&I Power Twelve Private LimitedSince 24 Aug 2026
12.44% bought in the quarter; holding 12.44%, from 0.00%
- Fine or penaltyEmployees' Provident Fund OrganisationSince 4 Aug 2026
Late payment of PF contribution to exited employees
Late payment of PF contribution to exited employees. - Tax disputeAssistant Commissioner of State Taxes, BangaloreSince 29 Sep 2026SCN issued proposing to demand tax liability of Rs. 7,75,584/- along with applicable interest and penalty
- Tax disputeAssistant Commissioner of State Taxes, BangaloreSince 10 Sep 2026SCN issued proposing to partially reject refund claim of unutilised ITC filed for the period Oct to Dec 2025
- Tax disputeAssistant Commissioner of State Taxes, HyderabadSince 15 Jul 2025
Appeal filed against the order dated 05-08-2025 of the jurisdictional authority before the First Appellate Authority has been dismissed vide order dated 27-07-2026. Company propose to file appeal before the GST Tribunal against the said order of the Appellate AuthorityMoreLess
At the filing before: Order dated 05-08-2025 issued partially rejecting the refund application filed in respect of exports made without payment of taxes
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.